This Supply and Quality Agreement (the "Agreement") is entered into and takes effect on [EFFECTIVE DATE] (the "Effective Date") by and between:

(1) ALDOCHEM EOOD, a single-member limited liability company incorporated under the laws of the Republic of Bulgaria, having its registered office at [REGISTERED ADDRESS], Burgas, Bulgaria, registered under Unified Identification Code (EIK) [UIC], acting for the purposes of this Agreement together with its GMP-aligned manufacturing partner located in Opole, Poland ("ALDOCHEM" or the "Supplier"); and

(2) [COUNTERPARTY NAME], a [LEGAL FORM] organised under the laws of [JURISDICTION], having its registered office at [COUNTERPARTY ADDRESS], registered under [REGISTRATION NUMBER] (the "Customer").

ALDOCHEM and the Customer are each referred to as a "Party" and together as the "Parties".

WHEREAS ALDOCHEM operates as a contract development and manufacturing organisation (CDMO) and sourcing platform for peptide products, offering custom peptide synthesis, raw peptide powder, in-stock research-use-only formats, and fill-and-finish services, and coordinates manufacturing through a GMP-aligned manufacturing partner situated in Opole, Poland;

WHEREAS the Customer wishes to purchase, and ALDOCHEM wishes to supply, certain peptide products intended solely for research use, in accordance with agreed specifications and the quality responsibilities set out in this Agreement;

WHEREAS the Parties operate, or wish to operate, under a commercial supply arrangement and wish to allocate between them the technical and quality responsibilities relating to the manufacture, testing, release, documentation, and traceability of the products supplied;

WHEREAS ALDOCHEM maintains an ISO 9001-style quality management system and applies manufacturing and testing practices aligned with the principles of good manufacturing practice (GMP), while the products are supplied for research use only and are not represented as GMP-certified, pharmaceutical-grade, or approved for human or veterinary administration;

NOW, THEREFORE, in consideration of the mutual covenants and undertakings set out below, and intending to be legally bound, the Parties agree as follows.

1.1 In this Agreement, unless the context otherwise requires, the following terms have the meanings assigned to them below.

1.2 "Batch" (or "Lot") means a defined quantity of a Product produced in a single manufacturing process or series of processes such that it is expected to be homogeneous within stated limits and identifiable by a unique batch or lot number.

1.3 "Batch Record" means the documentation associated with the manufacture and testing of a Batch, recording the materials used, the processing steps performed, the in-process and release testing conducted, and the personnel and dates involved.

1.4 "Certificate of Analysis" or "CoA" means the document issued for each Batch that states the analytical test results obtained against the applicable Specification and confirms the outcome of the review and release decision.

1.5 "Change Control" means the documented procedure by which proposed changes affecting a Product, its Specification, its manufacturing process, its testing methods, or associated documentation are reviewed, assessed, approved or rejected, and implemented.

1.6 "Confidential Information" has the meaning given in the confidentiality arrangements referenced in Clause 20.

1.7 "Deviation" means any departure from an approved instruction, procedure, Specification, or established process arising during the manufacture, testing, storage, or handling of a Product.

1.8 "GMP-Aligned" means manufacturing and quality practices designed and operated in accordance with the principles of good manufacturing practice, without any representation or warranty that any facility, process, or Product is certified, accredited, or licensed under any statutory GMP scheme.

1.9 "Manufacturing Partner" means the third-party manufacturing facility located in Opole, Poland engaged by ALDOCHEM to perform the manufacture and, where applicable, the testing of the Products, as further described in Clause 15.

1.10 "Out-of-Specification" or "OOS" means a test result that falls outside the acceptance criteria or limits set out in the applicable Specification.

1.11 "Product" means each peptide product identified in the Product Schedule at Clause 4, whether supplied as raw powder, in-stock research-use-only format, custom synthesis, or fill-and-finish output.

1.12 "QMS" means the quality management system maintained by ALDOCHEM, structured in accordance with ISO 9001-style principles.

1.13 "Research Use Only" or "RUO" means intended solely for laboratory research, testing, and development purposes, and not for use as, or in, a medicinal product, food, feed, cosmetic, or medical device, and not for administration to humans or animals.

1.14 "Specification" means the set of characteristics, acceptance criteria, and analytical methods applicable to a Product, as agreed in writing by the Parties under Clause 5.

1.15 In this Agreement: (a) headings are for convenience only and do not affect interpretation; (b) references to a "Clause" or "Schedule" are to a clause of or schedule to this Agreement; (c) the words "including", "include", and "in particular" are without limitation; (d) the singular includes the plural and vice versa; and (e) a reference to a statute or statutory provision is a reference to it as amended or re-enacted from time to time.

2.1 The purpose of this Agreement is to define and allocate the technical, quality, and documentation responsibilities of the Parties in connection with the manufacture, testing, release, supply, and traceability of the Products.

2.2 This Agreement governs quality matters only. Commercial terms, including pricing, order quantities, delivery terms, payment, and liability, are governed by the separate supply, framework, or purchase agreement between the Parties (the "Commercial Agreement").

2.3 In the event of a conflict between this Agreement and the Commercial Agreement, this Agreement prevails on matters of quality, and the Commercial Agreement prevails on commercial matters, unless the Parties expressly agree otherwise in writing.

2.4 Nothing in this Agreement obliges either Party to place or accept any particular order; the mechanism for placing and accepting orders is set out in the Commercial Agreement.

3.1 This Agreement applies to all Products listed in the Product Schedule at Clause 4 and supplied by ALDOCHEM to the Customer during the Term.

3.2 The Products are supplied for Research Use Only. The Customer acknowledges that the Products are not represented as suitable for, and must not be used for, any clinical, diagnostic, therapeutic, food, feed, or cosmetic application, or for administration to humans or animals.

3.3 The allocation of quality responsibilities between the Parties is summarised, where the Parties elect to prepare one, in a responsibility matrix appended as a Schedule; in the event of inconsistency between such matrix and the body of this Agreement, the body of this Agreement prevails.

3.4 Services or Products not expressly listed or described in this Agreement fall outside its scope unless the Parties agree otherwise in writing through Change Control.

4.1 The Products covered by this Agreement, and the format in which each is supplied, are set out in the product schedule below (the "Product Schedule").

4.2 Product: [PRODUCT NAME / PEPTIDE SEQUENCE OR REFERENCE]; Format: [RAW POWDER / IN-STOCK RUO / CUSTOM SYNTHESIS / FILL-AND-FINISH]; Applicable Specification reference: [SPEC ID / VERSION].

4.3 Product: [PRODUCT NAME / PEPTIDE SEQUENCE OR REFERENCE]; Format: [FORMAT]; Applicable Specification reference: [SPEC ID / VERSION].

4.4 The Product Schedule may be amended, and additional Products added, only by written agreement of the Parties through the Change Control procedure set out in Clause 8.

5.1 Each Product shall be manufactured, tested, and released against the applicable Specification agreed in writing by the Parties and identified in the Product Schedule.

5.2 The Specification shall define, at a minimum, the acceptance criteria for identity, purity, and appearance, the analytical methods to be applied, and any additional attributes agreed by the Parties (such as counterion, water content, or residual solvents, where applicable).

5.3 Where the Customer supplies or specifies a Specification, the Customer is responsible for the correctness, completeness, and fitness of that Specification for the Customer's intended research use. Where ALDOCHEM proposes a Specification, ALDOCHEM is responsible for its technical accuracy as against the intended manufacturing and testing process.

5.4 No amendment to a Specification is effective unless documented and approved by both Parties in writing through Change Control under Clause 8.

5.5 The current version of each Specification shall be retained by both Parties and shall govern the manufacture and release of Batches produced while that version is in effect.

6.1 ALDOCHEM shall manufacture, or procure the manufacture of, the Products in a manner aligned with the principles of good manufacturing practice and in accordance with the applicable Specification and agreed process documentation.

6.2 ALDOCHEM shall maintain a quality management system structured in accordance with ISO 9001-style principles, covering document control, personnel training, equipment and facility control, materials management, and records management.

6.3 The Parties acknowledge and agree that the manufacturing and quality practices are GMP-aligned only. Neither ALDOCHEM nor the Manufacturing Partner represents or warrants that any facility, process, or Product is GMP-certified, GMP-licensed, accredited under any statutory GMP scheme, or approved by any medicines or health authority.

6.4 The Products are manufactured and supplied for Research Use Only and are not manufactured to pharmacopoeial monograph standards unless the Parties expressly agree otherwise in writing for a specific Product.

6.5 ALDOCHEM shall ensure that personnel involved in the manufacture and testing of the Products are appropriately qualified, trained, and supervised for the tasks they perform.

6.6 ALDOCHEM shall procure that materials, reagents, and consumables used in the manufacture of the Products are controlled and, where relevant, tested or verified in accordance with the QMS.

7.1 ALDOCHEM shall not release a Batch for supply until it has been tested against, and found to conform with, the applicable Specification, and a Certificate of Analysis has been issued for that Batch.

7.2 Release testing shall include, as a minimum and where applicable to the Product: identity and purity determination by high-performance liquid chromatography (HPLC), and molecular mass confirmation by liquid chromatography-mass spectrometry (LC-MS), together with any further tests set out in the Specification.

7.3 The Certificate of Analysis for each Batch shall state the Product name and reference, the unique Batch or Lot number, the manufacturing and release dates, the tests performed, the acceptance criteria, the results obtained, and a statement of conformity with the Specification.

7.4 Each release decision shall be subject to a documented independent review. The analytical data and the release determination shall be verified and countersigned by a second qualified reviewer who did not perform the original testing, in accordance with the QMS (the "second-reviewer" or "four-eyes" principle).

7.5 ALDOCHEM shall provide the Customer with the Certificate of Analysis for each Batch supplied, either accompanying the Product or made available by the means agreed between the Parties.

7.6 The Customer shall inspect each delivery and review the accompanying Certificate of Analysis promptly on receipt and shall notify ALDOCHEM of any apparent discrepancy, defect, or non-conformity within [INSPECTION PERIOD] of receipt, without prejudice to the Customer's rights in respect of defects not reasonably discoverable on such inspection.

8.1 Neither Party shall implement any change that materially affects a Product, its Specification, its manufacturing process, its analytical methods, the Manufacturing Partner, or associated release documentation without following the Change Control procedure set out in this Clause 8.

8.2 The Party proposing a change shall notify the other Party in writing, describing the proposed change, its rationale, and its anticipated effect on the Product and its quality.

8.3 ALDOCHEM shall give the Customer prior written notice of any proposed change that ALDOCHEM classifies as significant, and shall not implement such change without the Customer's prior written approval, such approval not to be unreasonably withheld, conditioned, or delayed.

8.4 Changes required to comply with applicable law or regulatory requirements, or reasonably necessary to address an urgent safety or quality risk, may be implemented by ALDOCHEM without prior approval, provided that ALDOCHEM notifies the Customer as soon as reasonably practicable thereafter.

8.5 Each Party shall maintain records of proposed, approved, rejected, and implemented changes falling within this Clause 8 for the retention period set out in Clause 19.

9.1 ALDOCHEM shall record, assess, and investigate Deviations arising during the manufacture, testing, storage, or handling of a Product in accordance with the QMS.

9.2 Where a test result is determined to be Out-of-Specification, ALDOCHEM shall conduct a documented investigation to establish the cause and to determine whether the result is valid, and shall not release the affected Batch unless and until the investigation supports a conforming release decision.

9.3 ALDOCHEM shall notify the Customer without undue delay of any Deviation or OOS result that ALDOCHEM reasonably considers may affect the quality, identity, purity, or traceability of a Product already supplied, or of a Batch intended for supply, to the Customer.

9.4 A Batch affected by an unresolved Deviation or a confirmed OOS result shall not be supplied to the Customer as conforming Product unless the Parties expressly agree in writing to accept it under a documented concession, which agreement neither Party is obliged to give.

9.5 Records of Deviations, OOS investigations, and any resulting corrective and preventive actions shall be retained in accordance with Clause 19.

10.1 ALDOCHEM shall take and retain representative reference or retention samples of each Batch supplied, in sufficient quantity to permit, where reasonably practicable, confirmatory or investigative testing.

10.2 Retention samples shall be stored under conditions appropriate to the Product and shall be retained for a period of [RETENTION SAMPLE PERIOD] after the date of manufacture or such longer period as required by applicable law or agreed by the Parties.

10.3 Sampling shall be performed in accordance with documented procedures forming part of the QMS, in a manner designed to preserve the integrity and representativeness of the sample.

10.4 On the Customer's reasonable written request, and to the extent samples remain available, ALDOCHEM shall make retention sample information available in connection with an investigation, complaint, or audit.

11.1 Each Party shall promptly notify the other of any complaint, adverse quality observation, or product defect of which it becomes aware relating to a Product supplied under this Agreement.

11.2 ALDOCHEM shall record and investigate quality complaints relating to the Products in accordance with the QMS and shall communicate the outcome of its investigation to the Customer within a reasonable period.

11.3 The Customer shall provide ALDOCHEM with such information, samples, and reasonable assistance as ALDOCHEM may require to investigate a complaint, including, where available, the affected Batch or Lot number.

11.4 Where a quality defect may warrant the withdrawal or recall of a Product, the Parties shall consult with one another without undue delay and shall cooperate to identify the affected Batches, to trace the distribution of the affected Product to the extent within each Party's control, and to take appropriate corrective action.

11.5 Each Party shall bear responsibility for withdrawal or recall actions to the extent attributable to that Party's acts or omissions, without prejudice to the allocation of liability set out in the Commercial Agreement.

12.1 ALDOCHEM shall create and maintain a Batch Record for each Batch of Product, documenting the materials, processing steps, in-process controls, and release testing associated with that Batch.

12.2 Each Batch of Product shall be assigned a unique Batch or Lot number enabling lot-level traceability from the finished Product back to the principal materials used and forward to the deliveries made to the Customer.

12.3 ALDOCHEM shall maintain systems of identification and record-keeping sufficient to trace each Batch supplied to the Customer and to identify the Certificate of Analysis, Deviations, and change records associated with that Batch.

12.4 On the Customer's reasonable written request, ALDOCHEM shall make available a summary of the Batch Record or relevant traceability information for a Batch supplied to the Customer, subject to the confidentiality arrangements in Clause 20 and to redaction of information relating to third parties or proprietary processes.

12.5 Batch Records shall be retained in accordance with Clause 19.

13.1 The Customer may, on reasonable prior written notice of not less than [NOTICE PERIOD], conduct an audit of ALDOCHEM's quality systems and records relevant to the Products, no more than once in any [AUDIT FREQUENCY] period, save where a for-cause audit is justified by a material quality concern.

13.2 Audits shall be conducted during normal business hours, by a reasonable number of appropriately qualified representatives of the Customer, in a manner that does not unreasonably disrupt ALDOCHEM's operations, and subject to the confidentiality arrangements in Clause 20.

13.3 The Customer shall be entitled to review documentation relevant to the manufacture, testing, release, and traceability of the Products, but shall not be entitled to access information relating to other customers of ALDOCHEM or to proprietary or third-party confidential information.

13.4 Access to the Manufacturing Partner's premises is subject to the terms agreed between ALDOCHEM and the Manufacturing Partner; ALDOCHEM shall use reasonable endeavours to facilitate a reasonable and proportionate audit or on-site review of the Manufacturing Partner where relevant to the Products, subject to the Manufacturing Partner's consent and applicable confidentiality obligations.

13.5 The Customer shall provide ALDOCHEM with a written audit report within a reasonable period after the audit. ALDOCHEM shall respond to any findings and propose corrective actions where appropriate within a reasonable period, and shall implement agreed corrective actions in accordance with the QMS.

13.6 Each Party shall promptly inform the other of any inspection by a competent authority to the extent that inspection specifically concerns a Product supplied under this Agreement.

14.1 ALDOCHEM shall store and handle the Products prior to dispatch under conditions appropriate to preserve their quality, identity, and stability, in accordance with the QMS.

14.2 The Products shall be packaged and labelled to protect them during transport and to identify them, including the Product reference and Batch or Lot number, and to bear a research-use-only designation.

14.3 Risk, title, delivery terms, and transport arrangements are governed by the Commercial Agreement; where that agreement is silent, the Parties shall agree such terms in writing before dispatch.

14.4 On and from delivery, the Customer is responsible for storing, handling, and using the Products in accordance with any storage conditions stated on the label, the Certificate of Analysis, or accompanying documentation, and in accordance with good laboratory practice.

15.1 The Customer acknowledges and agrees that ALDOCHEM performs manufacture and, where applicable, testing of the Products through its Manufacturing Partner located in Opole, Poland, and may engage other qualified sub-tier suppliers in connection with the Products.

15.2 ALDOCHEM remains responsible to the Customer for the performance of the obligations under this Agreement that it subcontracts, as if ALDOCHEM had performed them itself.

15.3 ALDOCHEM shall ensure that the Manufacturing Partner and any other sub-tier supplier performing activities relevant to the quality of the Products is subject to quality obligations consistent with the relevant provisions of this Agreement, and shall maintain oversight of such suppliers through its QMS.

15.4 ALDOCHEM shall notify the Customer through Change Control under Clause 8 of any proposed change to the Manufacturing Partner performing the manufacture of a Product supplied to the Customer.

16.1 The Products are supplied within the European Union framework for Research Use Only. Each Party shall comply with the laws and regulations applicable to it in connection with the manufacture, supply, import, storage, handling, and use of the Products.

16.2 ALDOCHEM shall comply with its obligations under Regulation (EC) No 1907/2006 (REACH) and other applicable EU chemicals legislation to the extent applicable to the Products it supplies, and shall make available such safety and handling information as is appropriate to the Products, including a safety data sheet where required.

16.3 The Customer is responsible for determining and complying with the laws and regulations applicable to the Customer's import, possession, handling, and use of the Products in the Customer's territory, and for ensuring that its intended use is lawful and consistent with the Research Use Only designation.

16.4 The Customer shall not represent, label, resell, or supply the Products as suitable for human or animal administration, or as pharmaceutical-grade, GMP-certified, or clinically approved, and shall not use or distribute the Products in any manner inconsistent with the Research Use Only designation.

16.5 Each Party shall promptly inform the other of any regulatory development or communication of which it becomes aware that materially affects the lawful supply or use of a Product under this Agreement.

17.1 ALDOCHEM shall operate a documented process for identifying, implementing, and verifying corrective and preventive actions (CAPA) arising from Deviations, OOS results, complaints, audit findings, and other quality events.

17.2 Where a quality event relates to a Product supplied to the Customer, ALDOCHEM shall, on the Customer's reasonable request, provide a summary of the relevant corrective and preventive actions taken or planned.

17.3 Each Party shall implement corrective actions within its control within a reasonable period appropriate to the significance of the underlying event.

18.1 To the extent either Party processes personal data in connection with this Agreement, it shall comply with Regulation (EU) 2016/679 (the General Data Protection Regulation) and applicable Bulgarian data protection law.

18.2 The Parties anticipate that the performance of this Agreement will involve limited processing of personal data, principally business contact details of the Parties' personnel. Where the arrangement requires either Party to process personal data on behalf of the other, the Parties shall enter into a separate data processing agreement as required by Article 28 of the General Data Protection Regulation.

19.1 ALDOCHEM shall retain Batch Records, Certificates of Analysis, testing data, Deviation and OOS records, Change Control records, complaint records, and retention sample records for a period of not less than [RECORD RETENTION PERIOD] from the date of manufacture of the relevant Batch, or such longer period as required by applicable law or agreed by the Parties.

19.2 Records shall be retained in a legible, retrievable, and secure form, whether in paper or electronic format, in accordance with the QMS.

19.3 Before any records within the scope of Clause 19.1 are destroyed at the end of the applicable retention period, ALDOCHEM shall, where the Parties have so agreed in writing, offer the Customer the opportunity to request the transfer of copies of records relating to Products supplied to the Customer.

19.4 Each Party shall retain records relating to its own activities under this Agreement for at least the period set out in Clause 19.1 to the extent relevant to the traceability and quality of the Products.

20.1 Each Party shall keep confidential the Confidential Information of the other Party disclosed in connection with this Agreement and shall use it only for the purposes of performing this Agreement.

20.2 The confidentiality obligations of the Parties are governed by the separate confidentiality or non-disclosure agreement between the Parties dated [NDA DATE] (the "Confidentiality Agreement"), which is incorporated into this Agreement by reference. Where no such agreement is in force, the Parties shall be bound by customary obligations of confidentiality with respect to information disclosed as confidential or that ought reasonably to be understood to be confidential.

20.3 Nothing in this Clause 20 prevents disclosure of information that is or becomes public through no breach of the receiving Party, that was lawfully known to the receiving Party without obligation of confidence, or that is required to be disclosed by law or a competent authority, provided that, where lawful, the disclosing Party is given reasonable prior notice.

21.1 This Agreement takes effect on the Effective Date and, unless terminated earlier in accordance with its terms, continues for [TERM] and thereafter renews automatically for successive periods of [RENEWAL PERIOD] unless either Party gives written notice of non-renewal not less than [NOTICE PERIOD] before the end of the then-current period.

21.2 Either Party may terminate this Agreement by written notice if the other Party commits a material breach of this Agreement that is not remedied within [CURE PERIOD] after written notice specifying the breach and requiring its remedy, or that is incapable of remedy.

21.3 Either Party may terminate this Agreement by written notice with immediate effect if the other Party becomes insolvent, enters liquidation, has an administrator or receiver appointed, or is unable to pay its debts as they fall due, to the extent permitted by applicable law.

21.4 This Agreement shall terminate automatically on the expiry or termination of the Commercial Agreement, unless the Parties agree in writing that it shall continue.

21.5 On expiry or termination, the Parties shall complete the release and documentation obligations in respect of Batches already manufactured or in progress as the Parties may agree, and the provisions relating to record retention, retention samples, complaints and recalls, confidentiality, and any provision that by its nature is intended to survive shall continue in force.

22.1 Notices under this Agreement shall be in writing and given to the address or electronic address notified by each Party for that purpose, and shall be deemed received on delivery if by hand, on the second business day after posting if sent by recorded delivery, or on the day of transmission if sent by email during business hours (and otherwise on the next business day).

22.2 The initial contacts for quality and technical matters under this Agreement are: for ALDOCHEM, [ALDOCHEM QUALITY CONTACT]; and for the Customer, [CUSTOMER QUALITY CONTACT]. Either Party may change its nominated contact by written notice to the other.

23.1 This Agreement, together with the Commercial Agreement, the Confidentiality Agreement, the Specifications, and any Schedules referenced herein, constitutes the entire agreement between the Parties as to the quality matters it addresses and supersedes all prior understandings on those matters.

23.2 No variation of this Agreement is effective unless made in writing and signed by or on behalf of both Parties.

23.3 No failure or delay by a Party in exercising any right under this Agreement operates as a waiver of that right, and no single or partial exercise precludes any further exercise.

23.4 If any provision of this Agreement is held to be invalid or unenforceable, that provision shall be modified to the minimum extent necessary to make it valid and enforceable, or, if not possible, severed, and the remaining provisions shall continue in full force.

23.5 Neither Party may assign, transfer, or subcontract its rights or obligations under this Agreement without the prior written consent of the other Party, except that ALDOCHEM may subcontract manufacturing and testing activities as contemplated by Clause 15.

23.6 This Agreement does not create any partnership, joint venture, or relationship of agency between the Parties, and neither Party has authority to bind the other.

23.7 A person who is not a Party to this Agreement has no right to enforce any of its terms.

24.1 This Agreement, and any non-contractual obligations arising out of or in connection with it, are governed by and construed in accordance with the laws of the Republic of Bulgaria.

24.2 The Parties irrevocably submit to the exclusive jurisdiction of the competent courts of Burgas, Bulgaria in respect of any dispute or claim arising out of or in connection with this Agreement or its subject matter, without prejudice to any mandatory statutory rules of jurisdiction.

24.3 Before commencing proceedings, the Parties shall use reasonable endeavours to resolve any dispute amicably through good-faith discussion between their respective quality and management representatives.

IN WITNESS WHEREOF, the Parties have executed this Agreement as of the Effective Date.

For and on behalf of ALDOCHEM EOOD:

Signature: _______________________________

Name: [NAME]

Title: [TITLE]

Date: [DATE]

For and on behalf of [COUNTERPARTY NAME]:

Signature: _______________________________

Name: [NAME]

Title: [TITLE]

Date: [DATE]

This document is a template provided for general drafting purposes only. It is not legal advice and does not create any lawyer-client relationship. It must be reviewed, adapted, and approved by qualified legal counsel in the relevant jurisdiction before use, and completed with terms appropriate to the specific transaction and Parties.

The Products referenced in this template are supplied for Research Use Only. References to GMP-aligned manufacturing and an ISO 9001-style quality management system describe practices modelled on those standards and must not be read as claims of GMP certification, statutory GMP licensing, accreditation, or approval by any regulatory authority. Users must ensure that any quality, regulatory, and product-use representations are accurate for their circumstances before relying on this template.